Four bedside findings separated congestive heart failure from other causes of dyspnea

A simple clinical algorithm now appears able to sort dogs with myxomatous mitral valve disease into congestive heart failure or a noncardiac explanation for respiratory signs using only a few bedside variables. In a cohort of dogs first seen after a tentative diagnosis of CHF by first-opinion clinicians, the final model retained four features: a loud or palpable murmur, absence of sinus arrhythmia, tachypnea or dyspnea, and at least moderate left atrial enlargement.

The clinical appeal is obvious. Dogs with chronic degenerative mitral disease frequently arrive with cough, rapid breathing, exercise intolerance, or vague “not doing well” complaints, and the differential diagnosis can widen quickly once pulmonary disease, airway disease, and other noncardiac causes enter the frame. A method that leans on information available in routine examination and imaging can change the trajectory of triage before treatment decisions harden.

How the cohort was assembled and why the model stayed simple

Investigators collected data between November 2, 2015, and December 7, 2017, from dogs referred after a tentative CHF diagnosis. Each case was adjudicated as either CHF or subclinical MMVD with an alternate diagnosis explaining the clinical signs. The original algorithm included eight variables, but only the findings that actually improved diagnostic accuracy were kept.

That pruning matters because simpler rules tend to survive first-opinion use better than complex scoring systems. In busy practice, a tool has to work at the table, in the exam room, and during the first read of radiographs or echocardiographic findings. A model that depends on too many inputs can fail not because it is biologically wrong, but because it is too cumbersome to use when a coughing dog is in front of the clinician.

Murmur intensity and respiratory effort carried substantial weight

The study included 120 dogs: 46 with CHF and 74 with subclinical cardiac disease plus an alternate diagnosis for the presenting signs. Coughing was the referral complaint in 82 dogs, including 36 dogs with CHF, which reflects how often respiratory disease and cardiac disease compete for the same clinical space.

Every dog with CHF had a loud or palpable murmur, but so did 59 dogs without CHF. On its own, that finding cannot settle the question. In degenerative mitral valve disease, auscultation confirms cardiac disease but does not by itself distinguish compensated disease from decompensation. The murmur remains useful because it marks the substrate, not because it proves pulmonary edema.

Respiratory pattern sharpened the signal. All nonpanting dogs with CHF had tachypnea or dyspnea, while only 7 of 56 dogs without CHF showed that pattern. In practice, the distinction between a true cardiogenic increase in respiratory rate and respiratory noise from another cause can be clinically decisive. A dog with a murmur and normal breathing is very different from a dog with the same murmur plus persistent tachypnea at rest.

Left atrial enlargement anchored the cardiac diagnosis

Echocardiography added the structural confirmation the algorithm needed. Every dog with CHF had moderate-to-severe left atrial enlargement, compared with 25 of 35 dogs without CHF. Among the four retained variables, this finding likely supplies the strongest biological explanation for why the dog has crossed from chronic valve disease into failure: rising left-sided filling pressures drive atrial remodeling and eventually pulmonary venous congestion.

Absence of sinus arrhythmia also separated groups. Forty-five dogs with CHF lacked sinus arrhythmia, versus 26 without CHF. In a healthy or less compromised dog, respiratory sinus arrhythmia often persists; its disappearance can reflect a more stressed cardiopulmonary state and a loss of normal vagal modulation. It is a subtle sign, but in combination with dyspnea and atrial enlargement it helps move the probability toward CHF.

Diagnostic performance was strong when the variables were read in series

When the four findings were examined in series, the algorithm achieved sensitivity of 98% and specificity of 95% for diagnosing CHF. Those operating characteristics are unusually strong for a practical triage tool and support its use as a rapid decision aid in dogs with suspected MMVD-related respiratory distress.

The sequence matters because each variable contributes a different layer of evidence. The murmur identifies underlying mitral disease. Breathing pattern identifies active decompensation. Sinus arrhythmia adds physiologic context. Left atrial enlargement provides structural proof that the heart has advanced beyond a compensated state. Together, the combination mirrors how clinicians reason through a difficult case at the bedside, only in a more disciplined form.

A one-sentence takeaway is hard to avoid: this is a triage tool, not a replacement for clinical judgment.

What first-opinion clinicians can use now

For practitioners evaluating a dog with suspected MMVD and dyspnea, the study supports a compact approach: listen carefully for a loud or palpable murmur, assess respiratory rate and effort, look for sinus arrhythmia, and confirm whether left atrial enlargement is at least moderate. When all four features line up, CHF becomes much more likely. When several are absent, a noncardiac cause deserves greater weight.

The value of the algorithm lies in its restraint. It does not ask first-opinion clinicians to solve every respiratory presentation on the spot. It asks them to separate likely cardiac decompensation from look-alike illness using variables already embedded in routine veterinary assessment. For dogs with MMVD, that may reduce delay to appropriate therapy and avoid unnecessary treatment paths for noncardiac disease.

The study leaves one practical boundary intact: dogs that do not fit the pattern still require full diagnostic workup, especially when coughing, tachypnea, and murmur intensity do not align cleanly. Even so, the four-variable sequence gives clinicians a firmer starting point for deciding when dyspnea in MMVD is truly cardiac.


Reporting by Dr. Aishwarya N., MBBS for Medicine World Foundation, with additional data provided by PubMed / NCBI.